Cost-effectiveness of massively parallel sequencing for diagnosis of paediatric muscle diseases.
about
Prioritising the application of genomic medicine.Next Generation Sequencing Methods for Diagnosis of Epilepsy Syndromes.Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough SolutionsEconomic evaluation of genomic sequencing in the paediatric population: a critical review
P2860
Cost-effectiveness of massively parallel sequencing for diagnosis of paediatric muscle diseases.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Cost-effectiveness of massivel ...... of paediatric muscle diseases.
@en
Cost-effectiveness of massivel ...... of paediatric muscle diseases.
@nl
type
label
Cost-effectiveness of massivel ...... of paediatric muscle diseases.
@en
Cost-effectiveness of massivel ...... of paediatric muscle diseases.
@nl
prefLabel
Cost-effectiveness of massivel ...... of paediatric muscle diseases.
@en
Cost-effectiveness of massivel ...... of paediatric muscle diseases.
@nl
P2093
P2860
P50
P1433
P1476
Cost-effectiveness of massivel ...... of paediatric muscle diseases.
@en
P2093
Daniel G MacArthur
Gina L O'Grady
Joshua Burns
Kathryn N North
Lyndal Douglas
Mark Davis
Nigel F Clarke
Sarah A Sandaradura
P2860
P2888
P356
10.1038/S41525-017-0006-7
P577
2017-03-03T00:00:00Z